cytomegalovirus

(redirected from cytomegalovirus disease)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to cytomegalovirus disease: CMV

cy·to·meg·a·lo·vi·rus

 (sī′tə-mĕg′ə-lō-vī′rəs)
n. Abbr. CMV
Any of a group of herpesviruses that attack and enlarge epithelial cells. Such viruses also cause a disease of infants characterized by circulatory dysfunction and microcephaly.

cytomegalovirus

(ˌsaɪtəʊˈmɛɡələʊˌvaɪrəs)
n
(Microbiology) a virus of the herpes virus family that may cause serious disease in patients whose immune systems are compromised. Abbreviation: CMV

cy•to•meg•a•lo•vi•rus

(ˌsaɪ toʊˌmɛg ə loʊˈvaɪ rəs)

n., pl. -rus•es.
a herpesvirus that produces abnormal enlargement of epithelial cells, usu. mildly infectious but a cause of pneumonia in immunodeficient persons and severe systemic damage in the newborn.
[1960–65]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cytomegalovirus - any of a group of herpes viruses that enlarge epithelial cells and can cause birth defects; can affect humans with impaired immunological systems
herpes virus, herpes - any of the animal viruses that cause painful blisters on the skin
Translations

cy·to·meg·a·lo·vi·rus

n. citomegalovirus, grupo de virus pertenecientes a la familia Herpesviridae que infectan humanos y otros animales, y son causantes de la enfermedad de inclusión citomegálica.

cytomegalovirus (CMV)

n citomegalovirus m (CMV)
References in periodicals archive ?
Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to maribavir for treatment of clinically significant cytomegalovirus viremia and disease in at-risk patients, and the prevention and treatment of cytomegalovirus disease in patients with impaired cell mediated immunity, respectively.
Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to maribavir for treatment of clinically significant cytomegalovirus viremia and disease in at-risk patients, and treatment of cytomegalovirus disease in patients with impaired cell mediated immunity, respectively.
Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation.
UMass Medical School has had recent success bringing other ideas to market, most notably cytogam, a drug licensed to CSL Behring that blocks cytomegalovirus disease associated with organ transplantation; Clarinex, that ubiquitous allergy medicine; and through the medical device company Reflectance Medical Inc.
Pharmakokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.
In the announcement, HHS pointed out that there are still many problems associated with intestine transplants including high morbidity and mortality rates, frequent complications like acute and chronic rejections and serious infections like cytomegalovirus disease.

Full browser ?